» Articles » PMID: 25173879

Stem Cells in Canine Spinal Cord Injury--promise for Regenerative Therapy in a Large Animal Model of Human Disease

Overview
Publisher Springer
Specialty Cell Biology
Date 2014 Sep 1
PMID 25173879
Citations 31
Authors
Affiliations
Soon will be listed here.
Abstract

The use of cell transplantation for spinal cord injury is a rapidly evolving field in regenerative medicine. Numerous animal models are currently being used. However, translation to human patients is still a challenging step. Dogs are of increasing importance as a translational model for human disease since there is a greater awareness of the need to increase the quality of preclinical data. The use of dogs ultimately brings benefit to both human and veterinary medicine. In this review we analyze experimental and clinical studies using cell transplantation for canine spinal cord injury. Overall, in experimental studies, transplantation groups showed improvement over control groups. Improvements were measured at the functional, electrophysiological, histological, RNA and protein levels. Most clinical studies support beneficial effects of cell transplantation despite the fact that methodological limitations preclude definitive conclusions. However, the mechanisms of action and underlying the behavior of transplanted cells in the injured spinal cord remain unclear. Overall, we conclude here that stem cell interventions are a promising avenue for the treatment of spinal cord injury. Canines are a promising model that may help bridge the gap between translational research and human clinical trials.

Citing Articles

Beyond Canine Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells Transplantation: An Update on Their Secretome Characterization and Applications.

Merlo B, Iacono E Animals (Basel). 2023; 13(22).

PMID: 38003188 PMC: 10668816. DOI: 10.3390/ani13223571.


Convergence of human and veterinary medicine: leveraging canine naturally occurring neurological disorders to develop regenerative treatments.

Clark K, Amador A, Wang A Neural Regen Res. 2022; 18(3):541-542.

PMID: 36018168 PMC: 9727421. DOI: 10.4103/1673-5374.350195.


The Long-Term Efficacy Study of Multiple Allogeneic Canine Adipose Tissue-Derived Mesenchymal Stem Cells Transplantations Combined With Surgery in Four Dogs With Lumbosacral Spinal Cord Injury.

Chen C, Yang S, Wang I, Hsieh S, Yu J, Wu T Cell Transplant. 2022; 31:9636897221081487.

PMID: 35225026 PMC: 8894939. DOI: 10.1177/09636897221081487.


Systematic Evaluation of Spinal Cord Injury Animal Models in the Field of Biomaterials.

Verstappen K, Aquarius R, Klymov A, Wever K, Damveld L, Leeuwenburgh S Tissue Eng Part B Rev. 2021; 28(6):1169-1179.

PMID: 34915758 PMC: 9805871. DOI: 10.1089/ten.TEB.2021.0194.


Intrathecal Transplantation of Autologous and Allogeneic Bone Marrow-Derived Mesenchymal Stem Cells in Dogs.

Benavides F, Pinto G, Heckler M, Hurtado D, Teixeira L, Monobe M Cell Transplant. 2021; 30:9636897211034464.

PMID: 34427495 PMC: 8388229. DOI: 10.1177/09636897211034464.


References
1.
Neirinckx V, Cantinieaux D, Coste C, Rogister B, Franzen R, Wislet-Gendebien S . Concise review: Spinal cord injuries: how could adult mesenchymal and neural crest stem cells take up the challenge?. Stem Cells. 2013; 32(4):829-43. DOI: 10.1002/stem.1579. View

2.
Hardy S, Maltman D, Przyborski S . Mesenchymal stem cells as mediators of neural differentiation. Curr Stem Cell Res Ther. 2008; 3(1):43-52. DOI: 10.2174/157488808783489471. View

3.
Kepler C, Ponnappan R, Tannoury C, Risbud M, Anderson D . The molecular basis of intervertebral disc degeneration. Spine J. 2013; 13(3):318-30. DOI: 10.1016/j.spinee.2012.12.003. View

4.
Noble L, Wrathall J . Spinal cord contusion in the rat: morphometric analyses of alterations in the spinal cord. Exp Neurol. 1985; 88(1):135-49. DOI: 10.1016/0014-4886(85)90119-0. View

5.
Sofroniew M, Vinters H . Astrocytes: biology and pathology. Acta Neuropathol. 2009; 119(1):7-35. PMC: 2799634. DOI: 10.1007/s00401-009-0619-8. View